Headquartered in Westworks, White City Place, London, UK. Investors include Netherton Investments (a fund investing on behalf of Mike Platt) and Dompé farmaceutici S.P.A. For more information, visit ...
UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...
Scientists have developed a synthetic extracellular matrix (ECM) that can support the growth of a mini endometrium in a dish for at least two weeks. The endometrium -- the mucosal lining of the uterus ...
PITTSBURGH--(BUSINESS WIRE)--ECM Therapeutics, a clinical stage regenerative medicine company pioneering the development of Extracellular Matrix-based therapeutics for the treatment of unmet medical ...
“This review explores our current understanding of how ECM geometry influences the behaviors of both immune cells and tumor cells, which in turn impacts treatment efficacy and cancer evolutionary ...
A new study, led by Prof. Liu from the department of pharmacy, University of Electronic Science and Technology of China, discovered that the extracellular cell matrix (ECM) could induce the drug ...
(Nanowerk Spotlight) The extracellular matrix (ECM) is the complex network of proteins and sugars that provides structural and biochemical support for surrounding cells in the human body. This dynamic ...
Figure 1. (click to enlarge) Fibroblasts (blue DAPI stain) cultured on bead-like sphere structures produce embryonic ECM. Tissue engineering and regenerative medicine use various scaffolds, living ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback